Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Question-and-Answer SessionWell, so why don't we just start off with a little bit of an overview on Sana. I know you recently streamlined our pipeline to focus on SC451, which is your T1D islet cell product. And also SG293, which is your in vivo CAR T product. Just talk a little bit about that decision and what Sana looks like going forward?Steven HarrPresident, CEO & Director Sure. First of all, thanks, everybody, for joining us, both in the room and online. And I think you guys know we'll be making forwar ...